Your browser doesn't support javascript.
loading
Functional outcomes and survival after total glossectomy with laryngectomy: a systematic review.
Weyh, A M; Mosquera, C; Nedrud, S; Bunnell, A; Fernandes, R.
Affiliation
  • Weyh AM; Department of Oral and Maxillofacial Surgery, University of Illinois Chicago, Chicago, IL, USA.
  • Mosquera C; Department of Surgery, Division of Oral and Maxillofacial Surgery, University of Texas Medical Branch, Galveston, TX, USA.
  • Nedrud S; Private Practice, Jacksonville, FL, USA.
  • Bunnell A; Department of Oral and Maxillofacial Surgery, Division of Head and Neck Surgery, University of Florida College of Medicine, Jacksonville, FL, USA.
  • Fernandes R; Department of Oral and Maxillofacial Surgery, Division of Head and Neck Surgery, University of Florida College of Medicine, Jacksonville, FL, USA. Electronic address: rui.fernandes@jax.ufl.edu.
Article in En | MEDLINE | ID: mdl-39142962
ABSTRACT
Total glossectomy with laryngectomy (TGL) is a procedure with high morbidity/mortality risks reserved for cases of advanced tongue cancer with laryngeal invasion. This technique is controversial as there are significant impacts on quality of life, including loss of functional speech and swallowing. A systematic review was performed following the PRISMA guidelines with the primary goal of quantifying the functional outcomes and overall survival of patients undergoing TGL. The initial search resulted in 748 studies; seven of these met the inclusion criteria. Five studies evaluated functional speech postoperatively, and 12.1% (8/66) of patients in these studies achieved a form of functional speech. Most studies did not refer to the use of specific postoperative voice rehabilitation. Regarding swallowing function, 53.3% (32/60) of patients in five studies regained their ability to swallow. In six studies reporting gastrostomy tube dependence, 37.7% (29/77) of patients were tube-dependent. Recurrence within 1-year was reported in three studies; 52% (26/50) of the patients had recurrence within 1 year, and the 1-year disease-free survival rate was 48%. TGL is a highly invasive surgery; postoperatively, most patients do not regain the ability to speak, while only half are able to swallow. Despite these extreme efforts and sacrifices by the patient, approximately half of patients have a recurrence within the first year. The decision to perform a TGL should be made only in select and motivated patients after carefully explaining and weighing the oncological and quality of life risks and benefits.
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Int J Oral Maxillofac Surg Journal subject: ODONTOLOGIA Year: 2024 Document type: Article Affiliation country: United States Publication country: DENMARK / DINAMARCA / DK

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Int J Oral Maxillofac Surg Journal subject: ODONTOLOGIA Year: 2024 Document type: Article Affiliation country: United States Publication country: DENMARK / DINAMARCA / DK